|
THTPA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93745020027336E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.4022006606117E-11 |
| Normal-vs-Stage2 |
3.186200E-04 |
| Normal-vs-Stage3 |
6.04072347698548E-13 |
| Normal-vs-Stage4 |
3.10951264737014E-12 |
| Stage1-vs-Stage2 |
4.601900E-02 |
| Stage1-vs-Stage3 |
7.763800E-02 |
| Stage1-vs-Stage4 |
2.970200E-02 |
| Stage2-vs-Stage3 |
2.739500E-03 |
| Stage2-vs-Stage4 |
9.225900E-04 |
| Stage3-vs-Stage4 |
4.366800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54321000422897E-13 |
| Normal-vs-AfricanAmerican |
1.980340E-03 |
| Normal-vs-Asian |
8.67729999964872E-07 |
| Caucasian-vs-AfricanAmerican |
8.808300E-02 |
| Caucasian-vs-Asian |
2.167000E-01 |
| AfricanAmerican-vs-Asian |
5.021600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64201985342061E-13 |
| Normal-vs-Female |
1.53039803052479E-11 |
| Male-vs-Female |
4.229900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.02360350698427E-12 |
| Normal-vs-Age(41-60Yrs) |
3.73839958989208E-10 |
| Normal-vs-Age(61-80Yrs) |
5.22909493483326E-11 |
| Normal-vs-Age(81-100Yrs) |
3.74069999999893E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.990580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.746400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.894000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.868610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.893370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.877000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.20620016384055E-10 |
| Classical-VS-Follicular |
1.907620E-02 |
| Classical-VS-Other |
1.731980E-01 |
| Classical-VS-Normal |
1.70219394135529E-12 |
| Tall-VS-Follicular |
9.37270261403E-11 |
| Tall-VS-Other |
2.044200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.417800E-02 |
| Follicular-VS-Normal |
3.91630000000642E-05 |
| Other-VS-Normal |
1.75177999999221E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.40329999842592E-08 |
| Normal-vs-N1 |
8.12838685249062E-12 |
| N0-vs-N1 |
3.520900E-03 |
|
|
